The global high-throughput screening market size was worth around USD 18.93 Billion in 2021 and is projected to grow around USD 36.84 Billion by 2030, with a compounded annual growth rate of (CAGR) of roughly 7.82% from 2022 to 2030.
???? Click Here to access The Full market Report : https://www.zionmarketresearch.com/report/high-throughput-screening-market
➤ Rise in the utilization of high-throughput screening for drug development in order to augment market demand
The cost-effectiveness, seamless operation, and reduction in the time required for drug development by professionals have all contributed to a remarkable increase in the use of high-throughput screening for a variety of drug development procedures. The adoption of a sedentary lifestyle has resulted in a decrease in immunity, which is causing an increasing number of individuals worldwide to incur a variety of diseases. This has rendered them more susceptible to a variety of fatal and severe illnesses. Therefore, the global high-throughput screening market’s overall growth was significantly influenced by the development of pristinely effective medications for a variety of life-threatening diseases, which were not only designed for the geriatric population but also for the millennials.
➤ The market’s development is somewhat restricted by the necessity for a substantial capital investment in high-throughput screening.
A series of stages must be completed in high-throughput screening, including the development of assays, the preparation of reagents, the screening of compounds, the selection and characterization of targets, and the validation of hits in secondary assays. Depending on the complexity and time constraints of the objective, a professional may implement any of these procedures. However, the primary issue is that each of these procedures can be costly, which can make it challenging for numerous academic research laboratories to acquire any of these instruments, particularly when they have a restricted budget.
➤ The market is presented with lucrative opportunities due to the expansion of the pharmaceutical industry and the increasing investments in life science and research activities.
A substantial increase in the demand for superior and effective medications among individuals has resulted in a significant increase in interest among pharmaceutical companies to actively participate in drug discovery procedures. The governments of emerging economies, including India, China, and Brazil, have increased their funding to support the adoption of the most recent technologies and to further expand life science and research activities. This has created lucrative opportunities for market players due to their diversified healthcare markets, low labor and raw material costs, and increasing R&D costs. In the years ahead, these factors present lucrative prospects for the expansion of the global high-throughput screening market.
➤ The absence of competent professionals in developing and underdeveloped countries presents a significant obstacle to market expansion.
The operation of high-throughput screening instruments, such as multimode readers, flow cytometers, and liquid handling systems, necessitates a high level of expertise. Consequently, the market’s expansion is significantly hindered by the scarcity of proficient professionals who are capable of operating these exceptional instruments.
???? Get more info : https://www.zionmarketresearch.com/buynow/su/high-throughput-screening-market
The Global High-Throughput Screening Market is segmented based on product, application and region
Global High-Throughput Screening Market: Product Segment Analysis
● Reagents & Assay Kits
● Instruments
● Consumables & Accessories
● Software
● Services
Global High-Throughput Screening Market: Application Segment Analysis
● Target Identification and Validation
● Drug Discovery
● Primary and Secondary Screening
● Toxicology Assessment
Click on This Below Link to see Similar Reports :
https://www.linkedin.com/pulse/agriculture-equipment-market-size-industry-2w5kf/
https://www.linkedin.com/pulse/global-high-throughput-screening-market-industry-kkbgf/
https://www.linkedin.com/pulse/brain-health-supplements-market-share-size-sue1f/
https://www.linkedin.com/pulse/global-quantum-computing-market-analysis-drivers-q6r7f/
https://www.linkedin.com/pulse/sunflower-seeds-market-size-share-trends-industry-xoiwf/
https://www.linkedin.com/pulse/champagne-market-size-industry-trends-historical-zw3uf/
https://www.linkedin.com/pulse/refrigeratedfrozen-dough-products-market-size-w8c4f/
https://www.linkedin.com/pulse/global-tangential-flow-filtration-market-industry-uo2of/
https://www.linkedin.com/pulse/eubiotics-market-share-size-industry-forecast-4owvf/
https://www.linkedin.com/pulse/global-decentralized-finance-defi-market-analysis-wpfif/
https://www.linkedin.com/pulse/corporate-travel-market-size-share-trends-industry-gp1yf/
https://www.linkedin.com/pulse/online-grocery-delivery-services-market-size-xmyqf/
The global High-Throughput Screening market profiles key players such as:
● Agilent Technologies Inc
● Danaher Corporation
● Perkinelmer Inc.
● Thermo Fisher Scientific Inc
● Axxam S.P.A
● Tecan Group Ltd
● Bio-Rad Laboratories Inc.
● Hamilton Company
● Sigma-Aldrich Corporation
● Charles River Laboratories International Inc.
● Merck KGaA
● Corning Incorporated
● BioTek Instruments Inc.
● Aurora Biomed Inc.
● General Electric
● Beckman Coulter Inc.
● Luminex Corporation
● AstraZeneca
???? Recent Developments:
• The Automated Library Synthesis (ALiS) System was introduced by Particle Works, an innovative company that specializes in the development and production of cutting-edge particle engineering platforms, in November 2022. This innovative platform is designed to facilitate the high-throughput screening of lipid nanoparticle (LNP) formulations and mRNA candidates, as well as automation during the initial phases of drug development. Several unique advantages are offered by the futuristic ALiS platform, which is founded on microfluidic technology. The ALiS platform’s software enables the walk-away processing of up to 96 unique formulations in an average working day, which are derived from and bestowed upon covered 96-well plates. This is one of the most notable advantages.
• Twist Bioscience Corporation, a California-based company, announced the launch of its gene-to-antibody production platform, the Twist High Throughput Antibody Production, in April 2022. This platform enables customers to convert candidate DNA sequences into purified antibodies for a variety of screening applications and therapeutic discoveries.
➤ The market is anticipated to be dominated by the North American region during the forecast period.
The global high-throughput screening (HTS) market share was dominated by the North American market, and this trend is anticipated to persist throughout the forecast period. The primary factor contributing to the market’s expansion in this region is the government’s increased investment and funding, as well as the robust commercialization of pharmaceutical and biotechnology research. Furthermore, the market in this region is driven by the extensive implementation of innovative technologies and the persistent technological advancements in countries such as the United States and Canada.
???? Get Customization Report : https://www.zionmarketresearch.com/custom/1189
About Us :
Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database.
Be First to Comment